May 2019 – Mogrify strengthens team and relocates to the Bio-Innovation Centre, TusPark Cambridge

PRESS RELEASE 20th May 2019 Download PDF Mogrify strengthens team and relocates to the Bio-Innovation Centre, TusPark Cambridge Mogrify appoints 15 new staff including, Dr Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer   Cambridge, … Read More

April 2019 – Mogrify subsidiary Chondrogenix secures funding from SBRI Healthcare to advance regenerative cartilage therapy to the clinic

PRESS RELEASE 1st April 2019 Download PDF Mogrify subsidiary Chondrogenix secures funding from SBRI Healthcare to advance regenerative cartilage therapy to the clinic Chondrogenix will use Mogrify’s data-driven conversion platform to generate a safe, efficient and scalable source of cartilage … Read More

March 2019 – Mogrify wins Business Weekly award for ‘Disruptive Technology’ Direct cellular conversion technology recognized at prestigious business award

PRESS RELEASE 21st March 2019 Download PDF Mogrify wins Business Weekly award for ‘Disruptive Technology’ Direct cellular conversion technology recognized at prestigious business awards Cambridge, UK, 21st March 2019: Cell Mogrify Ltd (Mogrify), a UK company aiming to transform the … Read More

March 2019 – Mogrify awarded $555,000 USD (£420,000 GBP) Innovate UK funding to accelerate regenerative cell therapies

PRESS RELEASE 18th March 2019 Download PDF Mogrify awarded $555,000 USD (£420,000 GBP) Innovate UK funding to accelerate regenerative cell therapies Project to focus on data-driven cell conversions to produce cell therapies with potential application in wound healing, and oncology … Read More

February 2019 – Mogrify raises $3.7 million USD seed funding to accelerate its mission to transform cell therapy via direct cellular conversion

PRESS RELEASE 20th February 2019 Download PDF Mogrify raises $3.7 million USD seed funding to accelerate its missionto transform cell therapy via direct cellular conversion • Darrin M Disley, PhD, DSc, OBE, appointed as CEO• New investment from Ahren Innovation … Read More